TRENDING LISTS: Dividend Aristocrats, Dow 30, Largest Market Cap Stocks & Warren Buffett's Portfolio

BMRN $93.11 -0.78 (-0.83%)

Fri, Dec 14, 2018

BioMarin Pharmaceutical Inc is a Health Care stock that trades on the NASDAQ with a market cap of $9.41 Billion

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.

If you haven't signed up for Ebates yet, you are definitely leaving money on the table.

Get up to 12% CASH BACK from shopping @ $AMZN, $WMT and $EBAY & $10 Sign Up Bonus (through this link)!

Ebates Coupons and Cash Back

Add (BMRN) to Portfolio

BioMarin Pharmaceutical Inc Stock Charts

The 5 year and 1 year stock charts are below.

50 Day Moving Average

The 50 Day Moving Average is at $96.89 which is 3.9% above the stock price of $93.11.

200 Day Moving Average

The 200 Day Moving Average is at 93.43 which is 0.34% abovethe stock price of $93.11.

BMRN Stock Price

Below are a few key dates for the stock price.

Year To Date


The most recent stock price is $93.11.

The Year To Date (YTD) return is +2.28%.

52 Week Low


The 52 Week Low stock price is $76.01 set on Fri, Apr 6, 2018 which is 254 days ago.

The current price per share is 22.50% above the 52 week low.

52 Week High


The 52 Week High stock price is $106.07 set on Wed, Oct 17, 2018 which is 60 days ago.

The current price per share is -12.22% below the 52 week high.

All Time High

Jul 2015

The All Time High stock price is $149.13 set on Mon, Jul 20, 2015 which is 1,245 days ago.

The current price per share is -37.56% below the all time high.


Below is the EPS, P/E Ratio and Earnings Date.

The EPS is -$0.07 and the P/E Ratio is 0.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.


The Earnings Release Date for BioMarin Pharmaceutical Inc was Thu, Aug 2, 2018.

Since this earnings release 136 days ago, the stock price is down by -7.78%.


The most recent Earnings Release Date was on Thu, Oct 25, 2018, which was 52 days ago.

Since this earnings date, the stock price is up by +0.25%.

BioMarin Pharmaceutical Inc Dividend

Below is important Dividend information.

BMRN currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Industry Stocks

Below are some other Biotech & Pharma industry stocks like BioMarin Pharmaceutical Inc.